For the Inventor, By the Inventor

Enter assignee name

Brisbane, CA, United States of America

Second Genome, Inc.

USPTO Granted Patents = 11

CIPO Patents = 3

EPO Patents = 6

Trademarks = 1

Forward Citations = 10

Loading Chart...

Loading Chart...

22 inventors (with patents filed for the assignee):

Andrew Wonhee Han (9 out of 37 patents)

Karim Dabbagh (8 out of 12 patents)

Andrew Whitman Goodyear (7 out of 10 patents)

4. Todd Zachary DeSantis (6 out of 11 patents)

5. Tarunmeet Gujral (6 out of 9 patents)

6. Toshihiko Takeuchi (4 out of 22 patents)

7. Michi Izumi Willcoxon (4 out of 4 patents)

8. Stefanie Banas (4 out of 4 patents)

9. Ye Jin (4 out of 8 patents)

10. Todd Zachary Desantis (3 out of 3 patents)

11. Bernat Baeza Raja (2 out of 2 patents)

12. Shoko Kawana (2 out of 2 patents)

13. Mitsuko Lynn Yamamoto (2 out of 2 patents)

14. Nadir A Mahmood (1 out of 3 patents)

15. Peter DiStefano (1 out of 1 patent)

11 patents: Sort by Forward Citations

1. 12661383 - PROTEINS FOR THE TREATMENT OF EPITHELIAL BARRIER FUNCTION DISORDERS (2026-06-23),

2. 11666627 - Proteins for the treatment of epithelial barrier function disorders (2023-06-06),

3. 11505583 - Proteins for the treatment of epithelial barrier function disorders (2022-11-22),

4. 11473133 - Methods for validation of microbiome sequence processing and differential abundance analyses via multiple bespoke spike-in mixtures (2022-10-18),

5. 11389487 - as a biotherapeutic (2022-07-19),

6. 11344584 - as a biotherapeutic (2022-05-31),

7. 11273198 - Proteins for the treatment of epithelial barrier function disorders (2022-03-15),

8. 11207376 - Proteins for the treatment of epithelial barrier function disorders (2021-12-28),

9. 11174293 - Proteins for the treatment of epithelial barrier function disorders (2021-11-16),

10. 10251933 - Proteins for the treatment of epithelial barrier function disorders (2019-04-09),

11. 10150982 - Microbial ecology shift assay (2018-12-11),

Second Genome, Inc. is a biopharmaceutical company that utilizes microbiome science to discover and develop novel therapeutics. Through their innovative research, they aim to address unmet medical needs and improve patient outcomes. Their mission is to unlock the potential of the microbiome to transform human health.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Second Genome, Inc.

11 Patents

#14 in Brisbane, CA

#6,521 in California

#27,450 in US

#51,622 in the World

Brisbane, CA, United States of America

Second Genome, Inc.

Forward Citations = 10

22 inventors:

Andrew Wonhee Han (9 out of 37 patents)

Karim Dabbagh (8 out of 12 patents)

Andrew Whitman Goodyear (7 out of 10 patents)

4. Todd Zachary DeSantis (6 out of 11 patents)

5. Tarunmeet Gujral (6 out of 9 patents)

Please report any incorrect information to [email protected]

Loading…